Canadian Journal of Gastroenterology and Hepatology / 2018 / Article / Tab 2

Research Article

Efficacy and Safety of Immunosuppressive Therapy for PBC–AIH Overlap Syndrome Accompanied by Decompensated Cirrhosis: A Real-World Study

Table 2

Comparison of symptoms between the two groups at baseline.

SymptomsUDCA-only group (N=14)UDCA+IS group (N=14)P value

Jaundice3 (21.4%)6(42.9%)0.420
Ventosity5(35.7%)3(21.4%)0.678
Fatigue4(28.6%)3(21.4%)>0.999
Lower limb swelling3(21.4%)4(28.6%)>0.999
Anorexia2(14.3%)3(21.4%)>0.999
Arthralgia2(14.3%)4(28.6%)0.648
Yellow urine2(14.3%)3(21.4%)>0.999
Abdominal pain3(21.4%)2(14.3%)>0.999
Weight loss2(14.3%)1(7.2%)>0.999
Nausea1(7.2%)1(7.2%)-
None1(7.2%)1(7.2%)>0.999

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.